Evidence map›Paper›PMID 36423134›Full record

ArticleViruses2022

Stability and Feasibility of Dried Blood Spots for Hepatitis E Virus Serology in a Rural Setting.

Joakim Øverbø, Asma Aziz, K Zaman, Cathinka Halle Julin, Firdausi Qadri, Kathrine Stene-Johansen, Rajib Biswas, Shaumik Islam, Taufiqur Rahman Bhuiyan, Warda Haque and 3 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Joakim ØverbøNorwegian Institute of Public Health, NO-0213 Oslo, Norway.ORCID 0000-0002-1773-1622
Asma AzizDepartment of Microbiology, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway.ORCID 0000-0003-0203-5744
K ZamanInternational Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh.
Cathinka Halle JulinNorwegian Institute of Public Health, NO-0213 Oslo, Norway.ORCID 0000-0002-3934-7410
Firdausi QadriInternational Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh.
Kathrine Stene-JohansenNorwegian Institute of Public Health, NO-0213 Oslo, Norway.
Rajib BiswasInternational Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh.
Shaumik IslamInternational Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh.
Taufiqur Rahman BhuiyanInternational Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh.
Warda HaqueInternational Centre for Diarrheal Diseases Research, Dhaka 1212, Bangladesh.
Synne SandbuNorwegian Institute of Public Health, NO-0213 Oslo, Norway.
Jennifer L DembinskiNorwegian Institute of Public Health, NO-0213 Oslo, Norway.ORCID 0000-0001-9259-9572
Susanne DudmanDepartment of Microbiology, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway.ORCID 0000-0001-5047-4982
International Centre for Diarrhoeal Disease Research · BDNorwegian Institute of Public Health · NOInternational Vaccine Institute · KROslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis worldwide. In many low-income countries it causes large outbreaks and disproportionally affects pregnant women and their offspring. Surveillance studies to find effective preventive interventions are needed but are hampered by the lack of funding and infrastructure. Dried blood spots (DBS) offer an easier and more robust way to collect, transport, and store blood samples compared to plasma/serum samples, and could ease some of the barriers for such studies. In this study we optimize an HEV IgG ELISA for DBS samples and validate it on 300 paired DBS and plasma samples collected in rural areas of Bangladesh from participants in a HEV vaccine study. We demonstrate that HEV IgG in blood stored as DBS is stable for two months at up to 40 °C, and for five freeze-thaw cycles. The specificity was 97% and the overall sensitivity of the DBS assay was 81%. The sensitivity was higher in samples from vaccinated participants (100%) compared to previously infected participants (59%), reflecting a positive correlation between IgG titer and sensitivity. We found a strong correlation between DBS and plasma samples with an r2 of 0.90, but with a higher degree of difference between individual paired samples. Our study shows that DBS offers a stable alternative to plasma/serum for HEV IgG measurements and can facilitate serological studies, particularly in resource limited areas.

Indexed as

Hepatitis E virusFeasibility StudiesFemaleHematologic TestsHepatitis AntibodiesHumansImmunoglobulin GPregnancyHepatitis AntibodiesImmunoglobulin GDBSdried blood spothepatitis EHEVIgGserologyvaccine

Identifiers

PMID36423134
PMCPMC9692628
OpenAlexW4309113431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.